AMLYCAS Trademark Information

PROTHENA BIOSCIENCES LIMITED

Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of autoimmune, metastatic, hematologic, oncologic, ocular and neurologic diseases, conditions and disorders; Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders associated with misfolded proteins; Biopharmaceuticals and pharmaceuticals for the preve...

Perfect for these industries

This is a brand page for the AMLYCAS trademark by PROTHENA BIOSCIENCES LIMITED  in Grand Canal Docklands, Dublin 2, , D02T804.

Write a review about a product or service associated with this AMLYCAS trademark. Or, contact the owner PROTHENA BIOSCIENCES LIMITED of the AMLYCAS trademark by filing a request to communicate with the Legal Correspondent for licensing, use, and/or questions related to the AMLYCAS trademark.

Status Update! On Thursday, November 12, 2020, status on the AMLYCAS trademark changed to SECOND EXTENSION - GRANTED.

On Friday, October 20, 2017, a U.S. federal trademark registration was filed for AMLYCAS. The USPTO has given the AMLYCAS trademark serial number of 87653874. The current federal status of this trademark filing is SECOND EXTENSION - GRANTED. The correspondent listed for AMLYCAS is JENNIFER L. DEAN of FAEGRE DRINKER BIDDLE & REATH LLP, SUITE 1100, 1500 K STREET, NW WASHINGTON, DC 20005 . The AMLYCAS trademark is filed in the category of Pharmaceutical Products . The description provided to the USPTO for AMLYCAS is Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of autoimmune, metastatic, hematologic, oncologic, ocular and neurologic diseases, conditions and disorders; Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders associated with misfolded proteins; Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders affecting the central nervous system; Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of amyloidosis, psoriasis, psoriatic arthritis, rheumatoid arthritis, dermatitis, host and graft rejections, Alzheimer's and Parkinson's-disease associated neuropsychiatric disorders, insulin resistance, metabolic syndrome and diabetes.

Word mark: AMLYCAS
Status/Status Date:
SECOND EXTENSION - GRANTED
11/12/2020
Serial Number: 87653874
Filing Date: 10/20/2017
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of autoimmune, metastatic, hematologic, oncologic, ocular and neurologic diseases, conditions and disorders; Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders associated with misfolded proteins; Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of diseases, conditions and disorders affecting the central nervous system; Biopharmaceuticals and pharmaceuticals for the prevention, treatment, management, diagnosis and prognosis of amyloidosis, psoriasis, psoriatic arthritis, rheumatoid arthritis, dermatitis, host and graft rejections, Alzheimer's and Parkinson's-disease associated neuropsychiatric disorders, insulin resistance, metabolic syndrome and diabetes
Mark Description: NOT AVAILABLE
Type Of Mark: TradeMark
Published For Opposition Date: 4/9/2019
Last Applicant/Owner: PROTHENA BIOSCIENCES LIMITED
Grand Canal Docklands, Dublin 2 D02T804
Mark Drawing Code: Standard Character Mark
Design Search: (NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
FAEGRE DRINKER BIDDLE & REATH LLP
SUITE 1100
1500 K STREET, NW
WASHINGTON, DC 20005

Classification Information

Intent to Use Trademark - Applicant has not submitted proof of use in commerce the the USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere: : Not provided
First Use In Commerce: Not provided

Trademarkia is the largest search engine for U.S. trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia Network Law firms! You can register your trademark in 170+ countries in the world through Trademarkia Network Law firms.

Trademarkia-Network law firms can help you incorporate a business around your AMLYCAS trademark in less than 5 minutes. Trademarkia makes the process easy and convenient, so start now!

Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

Trademark Document Retrieval >>

100% Satisfaction Guarantee protect your valuable brand now.

  • 1. Trademarkia Network law firm - #1 U.S. Trademark Filing from 2010 to now.
  • 2. Describe how your business or product is being used. Register your mark in 176+ countries. Starting $399/class + govt fees! Click here >>
  • 1. Top Global Specialist - Credibility and Experience!
  • 2. All processes will be performed in a timely manner.
Current Trademark Status:
11/12/2020
SECOND EXTENSION - GRANTED
Correspondent Search:

JENNIFER L. DEAN is a correspondent of AMLYCAS trademark.

Current Overall Rating:
RatingRatingRatingRatingRating (0 review)
What You Can Do: